SecBot SecBot
8-K ·Filed Aug 10, 2026

SGHT

Sight Sciences, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed2mo ago SEC0001193125-26-341346
8-K context-dependent: Items 5.02
Actionable Insight • Neutral

No trading signal. This is a standard C-suite legal officer transition with orderly succession and no unexpected departures. Monitor next quarterly filing for any changes in legal strategy or litigation exposure that could affect the business.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d
SGHT ▲ +5.19% at T+20d
NEUTRAL call +5.19% · α vs SPY +6.11% · entry $7.70 → $8.10
Next anchor: T+60d in 7d
Latest observation: T+53 -8.28% FF3 residual α
Entry = T+0 close
Aug 10, 2026
via day close
T+1d
+0.65%
call +0.65% · α +0.97%
$7.75
settled 3mo ago
T+5d
+7.01%
call +7.01% · α +7.06%
$8.24
settled 2mo ago
T+20d
+5.19%
call +5.19% · α +6.11%
$8.10
settled 7w ago
T+60d
Pending
in 7d

Price Chart

Loading chart...

Executive Summary

Sight Sciences appointed Kashif Rashid as Chief Legal Officer and Corporate Secretary effective August 10, 2026, replacing Jeremy Hayden who resigned to pursue other opportunities and will assist with transition through August 31. The filing is a routine officer succession with standard compensation terms and no financial impact on the company's operations or outlook.

Key Facts

  • Kashif Rashid appointed Chief Legal Officer and Corporate Secretary, effective August 10, 2026
  • Jeremy Hayden resigned as Chief Legal Officer, effective August 10, 2026, and will remain employed through August 31 for transition
  • Rashid receives $450,000 base salary, 50% target bonus, and $1.4M RSU award vesting over 4 years
  • Hayden eligible for one year base salary severance and up to one year COBRA upon signing separation agreement

Financial Impact

No material financial impact. Compensation and severance are routine for a mid-cap medical device company.

Risk Factors

  • Loss of institutional knowledge with outgoing CLO; transition period is brief (3 weeks)

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
71% bullish (14 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-341346
Document: 0001193125-26-341346-index-headers.html0001193125-26-341346
Document: 0001193125-26-341346-index.html0001193125-26-341346
Document: 0001193125-26-341346.txt0001193125-26-341346
9 reports for SGHT
Performance horizon
67% Hit rate @ T+5 2 of 3 directional calls Went positive at some point 3 of 3 best @ T+60▲ +16.67%Apr 23, 2026
Filters
Rows
Reports for SGHT — sortable, filterable
TypeNow
Oct 21, 2026
5d ago
Press Release
NEUTRAL ★ 1/10
$9.09awaiting T+5—$9.02 (−0.77%)
Oct 5, 2026
21d ago
Insider Cluster
NEUTRAL ★ 3/10
$8.56 $8.39▼ −1.99%▼ −1.85%$9.02 (+5.37%)
Aug 10, 2026
11w ago
8-K
NEUTRAL ★ 2/10
$7.70 $8.24▲ +7.01%▲ +7.06%$9.02 (+17.14%)
Jul 6, 2026
16w ago
Insider Cluster
BEARISH ★ 5/10
$5.35 $5.05▲ +5.61%▲ +6.16%$9.02 (−68.60%)
Apr 23, 2026
26w ago
8-K
BULLISH ★ 8/10
$4.32 $3.97▼ −8.10%▼ −9.58%$9.02 (+108.80%)
Apr 21, 2026
26w ago
Press Release
NEUTRAL ★ 1/10
$4.27 $4.30▲ +0.70%▲ +0.65%$9.02 (+111.24%)
Apr 1, 2026
29w ago
Insider Cluster
BEARISH ★ 5/10
$3.66 $3.50▲ +4.37%▲ +8.14%$9.02 (−146.45%)
Mar 4, 2026
33w ago
8-K
MIXED ★ 6/10
$3.96 $3.62▼ −8.59%▼ −6.35%$9.02 (+127.78%)
Mar 4, 2026
33w ago
Press Release
MIXED ★ 6/10
$3.96 $3.62▼ −8.59%▼ −6.35%$9.02 (+127.78%)
Showing 9 of 9

US Market Status

Market Closed — Opens in 9h 8m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 10, 2026